The use of ritodrine in the treatment of premature labour.
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D001034:Apgar Score; D002584:Cervix Uteri / Q000187:drug effects; D005260:Female; D005313:Fetal Death; D005318:Fetal Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007743:Labor, Obstetric / Q000187:drug effects; D009325:Nausea / Q000139:chemically induced; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010627:Phenethylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010636:Phenols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011412:Propanolamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014599:Uterus / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
D000318:Adrenergic beta-Agonists; D010627:Phenethylamines; D010636:Phenols; D011412:Propanolamines